Filing Details
- Accession Number:
- 0001213900-15-009532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-17 09:35:22
- Reporting Period:
- 2015-12-16
- Filing Date:
- 2015-12-17
- Accepted Time:
- 2015-12-17 09:35:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1630639 | Shreeram Agharkar | C/O Relmada Therapeutics, Inc. 757 Third Avenue, Suite 2018 New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-16 | 1,000 | $3.45 | 5,259 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-12-16 | 100 | $3.25 | 5,359 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |